Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial (Q35994341)

11 August 2017

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.243

11 August 2017

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.243

19 October 2022

main subject

phase I clinical trial

0 references

1 reference

19 October 2022

1

M. H. Gilleece

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

7

P. Stern

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

author name string

J. H. Scarffe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

A. Ghosh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

C. M. Heyworth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

E. Bonnem

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

N. Testa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

T. M. Dexter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

19 October 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC1977892

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

https://europepmc.org/articles/PMC1977892?pdf=render

19 October 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1637669

https://www.nature.com/articles/bjc1992243.pdf

19 October 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.243

https://www.nature.com/articles/bjc1992243

19 October 2022

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.243

British Journal of Cancer

19 October 2022

published in

1 reference

11 August 2017

66

1 reference

11 August 2017

1

1 reference

11 August 2017

204-210

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1992.243

11 August 2017

0 references

cites work

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Differential regulation of IgG1 and IgE synthesis by interleukin 4.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Fc epsilon RII/CD23: the low affinity receptor for IgE.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Interleukin-4: a prototypic immunoregulatory lymphokine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Characterization of the human B cell stimulatory factor 1 receptor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

IL-4 regulates differentiation and proliferation of human precursor B cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Murine interleukin-4 displays potent anti-tumor activity in vivo

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Inhibition of human macrophage colony formation by interleukin 4.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977892

High affinity binding of human interleukin 4 to cell lines

11 July 2018

1 reference

12 December 2020

Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells

1 reference

12 December 2020

Recombinant interleukin 4 (RIL4) inhibits interleukin 2-induced activation of peripheral blood lymphocytes

1 reference

12 December 2020

Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling

1 reference

12 December 2020

Recombinant interleukin 4 promotes the growth of human T cells

1 reference

12 December 2020

Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation

1 reference

12 December 2020

Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients

1 reference

12 December 2020

Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1992.243

1 reference

release_ytm3yxmrgjdwdi6whlezs7q4qi

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ytm3yxmrgjdwdi6whlezs7q4qi

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

1 reference